Jean-Philippe Leduc-Gaudet

McGill

5

Sessions in which Jean-Philippe Leduc-Gaudet attends

Monday 23 November, 2020

Time Zone: (GMT-05:00) Eastern Time (US & Canada)

9:30 AM

Decorative image for session Welcome from the director

Welcome from the director

9:30 AM - 9:45 AM | 15 minutes

9:45 AM

Decorative image for session Session 1: The research of the members

Session 1: The research of the members

9:45 AM - 11:30 AM | 1 hour 45 minutes

10:15 AM

Effet de mutations dans la protéine TBC1D24 associée au syndrome DOORS sur la dynamique mitochondriale

10:15 AM - 11:30 AM | 1 hour 15 minutes

10:30 AM

Comprendre la réponse positive induite par l’entraînement physique observée chez la population atteinte de dystrophie myotonique de type 1 par la protéomique

10:30 AM - 11:45 AM | 1 hour 15 minutes

10:45 AM

Biallelic variants in the transcription factor PAX7 are a new genetic cause of Myopathy

10:45 AM - 11:00 AM | 15 minutes

11:00 AM

Exploiting the conformational regulation of ELMO proteins reveals that myoblast fusion can be exploited for regenerative therapies in muscle diseases

11:00 AM - 11:15 AM | 15 minutes

11:30 AM

ALS gene, C9orf72, loss of function Zebrafish model shows motor and synaptic defects

11:30 AM - 12:30 PM | 1 hour

Mitochondria-Derived Vesicles prevent inflammation by controlling the inclusion of mitochondrial proteins into extracellular vesicles

11:30 AM - 12:30 PM | 1 hour

Novel neurodevelopmental genes in C. elegans

11:30 AM - 12:30 PM | 1 hour

Drug repurposing for Duchenne Muscular Dystrophy using phenotype-based drug screening

11:30 AM - 12:30 PM | 1 hour

L’interaction entre progéniteurs fibro-adipogéniques et médiateurs lipidiques, le nouvel orchestre de la régénération musculaire

11:30 AM - 12:30 PM | 1 hour

CLN5 and CLN3 function as a complex to regulate endosome-to-TGN trafficking

11:30 AM - 12:30 PM | 1 hour

Preliminary Results on Novel Gene Involved in Regulating Differentiation of C2C12 Myoblasts

11:30 AM - 12:30 PM | 1 hour

Targeting muscle stem cells as a therapeutic approach for myotonic dystrophy type 1

11:30 AM - 12:30 PM | 1 hour

We use cookies

We use our own and third-party cookies to personalize content and to analyze web traffic. Read more about cookies